KUALA LUMPUR: The Drug Control Authority has issued orders to remove health products containing sibutramine from the market, as it was found to increase the risk of adverse cardiovascular effects such as heart attack and stroke.
Health director-general Tan Sri Dr Mohd Ismail Merican, in a statement, said the decision to recall and suspend the regisration of products containing the substance was based on a Sibutramine Cardiovascular Outcomes study conducted by Abbot Laboratories on the product, Reductil.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!